🇫🇷 Kyprolis in France

Kyprolis (carfilzomib) regulatory status in France.

Marketing authorisation

ANSM

  • Local brand name: Kyprolis
  • Status: approved

Kyprolis in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Oncology approved in France

Frequently asked questions

Is Kyprolis approved in France?

Yes. ANSM has authorised it.

Who is the marketing authorisation holder for Kyprolis in France?

Amgen is the originator. The local marketing authorisation holder may differ — check the official source linked above.